Genetic variants in KCNA5 have also been found in patients with PAH, as well as reduced expression and activity of Kv1.5, encoded by KCNA5, however the exact mechanism is still relatively unknown [[8], [9]]. Here, KCNA5 is linked to pulmonary arterial hypertension.